Synlogic Valuation
| SYBX Stock | USD 1.38 0.02 1.43% |
Today, the company appears to be overvalued. Synlogic has a current Real Value of $1.09 per share. The regular price of the company is $1.38. Our model measures the value of Synlogic from inspecting the company fundamentals such as Shares Owned By Insiders of 14.19 %, return on equity of -1.32, and Current Valuation of (3.25 M) as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Synlogic's price fluctuation is very risky at this time. Calculation of the real value of Synlogic is based on 3 months time horizon. Increasing Synlogic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Synlogic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Synlogic Stock. However, Synlogic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.38 | Real 1.09 | Hype 1.38 | Naive 1.45 |
The intrinsic value of Synlogic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Synlogic's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Synlogic helps investors to forecast how Synlogic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Synlogic more accurately as focusing exclusively on Synlogic's fundamentals will not take into account other important factors: Synlogic Total Value Analysis
Synlogic is at this time forecasted to have valuation of (3.25 M) with market capitalization of 16.14 M, debt of 17.27 M, and cash on hands of 106.79 M. The negative valuation of Synlogic may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Synlogic fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(3.25 M) | 16.14 M | 17.27 M | 106.79 M |
Synlogic Investor Information
About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.23. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Synlogic recorded a loss per share of 1.5. The entity last dividend was issued on the 28th of August 2017. The firm had 1:7 split on the 28th of August 2017. Based on the measurements of operating efficiency obtained from Synlogic's historical financial statements, Synlogic is not in a good financial situation at this time. It has a very high odds of going through financial crisis in March.Synlogic Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Synlogic has an asset utilization ratio of 4.46 percent. This suggests that the Company is making $0.0446 for each dollar of assets. An increasing asset utilization means that Synlogic is more efficient with each dollar of assets it utilizes for everyday operations.Synlogic Ownership Allocation
The market capitalization of Synlogic is $16.14 Million. Over half of Synlogic's outstanding shares are owned by institutional holders. These institutional holders are typically referred to as corporate investors that take positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.Synlogic Profitability Analysis
The company reported the previous year's revenue of 3.37 M. Net Loss for the year was (57.28 M) with profit before overhead, payroll, taxes, and interest of 2.78 M.About Synlogic Valuation
Our relative valuation model uses a comparative analysis of Synlogic. We calculate exposure to Synlogic's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Synlogic's related companies.Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc. for the research and pre-clinical development of a synthetic biotic medicine for the treatment of inflammatory bowel disease and Ginkgo Bioworks, Inc. Synlogic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 84 people.
Synlogic Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 6.5 M |
Additional Tools for Synlogic Stock Analysis
When running Synlogic's price analysis, check to measure Synlogic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synlogic is operating at the current time. Most of Synlogic's value examination focuses on studying past and present price action to predict the probability of Synlogic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synlogic's price. Additionally, you may evaluate how the addition of Synlogic to your portfolios can decrease your overall portfolio volatility.